Literature DB >> 17313564

Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.

George Mantzios, Panagiotis Tsirigotis, Vassiliki Pappa, Konstantina Spirou, Vassiliki Giannopoulou, Irene Kaitsa, Konstantinos Girkas, Efstathios Papageorgiou, John Dervenoulas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17313564     DOI： 10.1111/j.1600-0609.2006.00799.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  4 in total

Review 1.  The use of recombinant activated factor VII in platelet disorders: a critical review of the literature.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

2.  Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.

Authors:  Jason M Elinoff; Ulas Bagci; Brad Moriyama; Jennifer L Dreiling; Brent Foster; Nicole J Gormley; Rachel B Salit; Rongman Cai; Junfeng Sun; Andrea Beri; Debra J Reda; Farhad Fakhrejahani; Minoo Battiwalla; Kristin Baird; Jennifer M Cuellar-Rodriguez; Elizabeth M Kang; Stephen Z Pavletic; Dan H Fowler; A John Barrett; Jay N Lozier; David E Kleiner; Daniel J Mollura; Richard W Childs; Anthony F Suffredini
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-20       Impact factor: 5.742

3.  Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients.

Authors:  Farjah H AlGahtani; Mashael Alshaikh; AbdulRehman AlDiab
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

4.  Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias.

Authors:  Gülsüm Emel Pamuk; Murat Taşçi; Erman Oztürk; Muzaffer Demir
Journal:  Med Oncol       Date:  2009-01-10       Impact factor: 3.064
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.